Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Peritoneal Neoplasms × Oxaliplatin × Clear all

Phase

Phase 2 6 Phase 1 3 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 28 Pancreatic Neoplasms 23 Rectal Neoplasms 18 Stomach Neoplasms 15 Colonic Neoplasms 15 Esophageal Neoplasms 9 Lymphoma, Large B-Cell, Diffuse 6 Neoplasm Metastasis 5 Gastrointestinal Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Ovarian Neoplasms 4 Liver Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Adenocarcinoma Of Esophagus 4 Gallbladder Neoplasms 3 Cholangiocarcinoma 3 Biliary Tract Neoplasms 3 Advanced Solid Tumor 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Diabetes Mellitus, Insulin-Dependent, 12 2 Colorectal Cancer Metastatic 2 Bile Duct Neoplasms 2 Advanced Solid Tumors 2 Adenocarcinoma 2 Solid Cancer 1 Recurrence 1 Phase I: To Determine the Maximum Tolerated Dose (MTD) 1

Interventions

tremelimumab 1 poly(I).poly(c12,U) 1 olaparib 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 genexol-PM 1 abagovomab 1 Paclitaxel 1 Oxaliplatin 1 MOC31PE immunotoxin 1 Introns 1 Interferon alpha-2 1 Hyperthermic Intraperitoneal Chemotherapy 1 Drug Therapy 1 Doxorubicin 1 Cytoreduction Surgical Procedures 1 Cisplatin 1 Celecoxib 1 Bevacizumab 1 AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase 1 Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02604784 2020-09-17

PI-CaP

Fondazione del Piemonte per l'Oncologia

Phase 1/2 Completed

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡